David Grand and Bazelet Research received no
Federal of State funding and complied with all state, federal, and global law in cannabis and is in compliance to all federal opportunities as registered and licensed.
BAZELET HEALTH 2020
Challenges in defining appropriate levels of THC in legislation
The legislative framework originally intended for the hemp industry, which is based on the percentage of THC in hemp, is not appropriate for the many variants of cannabis product that have recently appeared on the market and should not be used as surrogate safety limits for human consumption without further checks.
The percentage of THC can be measured and referred to at a variety of levels. The level of THC that a certain variety of cannabis plant will usually produce. This serves to distinguish between legal hemp and illegal cannabis. The levels found in the different parts of the plant. Levels are lowest in the roots, stalks and seeds, higher in the leaves and highest in flowers and resin. This serves to distinguish what parts of the plant may be used for industrial purposes without extensive testing, or what might be of value to divert to illegally extracting THC.
The level found in the extracts. This may be used to indicate whether an extract (usually oil) has intoxicating properties or not. The level found in the final consumable product, for example an edible product.The input (ingredient) is easier for the producer to control, but the output (product) is more relevant when considering the effect on the consumer. Nevertheless, it is possible to grow low-THC hemp and from it produce a high THC extract, highlighting the importance of considering the final product and not just the input material.
Currently there may be inconsistency between laws applying to industrial uses and narcotics laws with respect to whether percentage or weight is used to determine the amount of THC in a product. It may
be possible for a product (e.g. oil) containing a low percentage of THC that is within the permitted industrial levels to exceed the total weight of THC permitted under narcotics laws. For example, 500 millilitres of ‘CBD oil’ containing 0.2 % THC will contain approximately 1 gram of THC, a threshold for narcotics possession or sale offences in some countries. Canada and the state of Colorado followed in Florida have set limits of 10 milligrams of THC in one ‘unit’ of a (recreational/medical) edible product for intoxication, such as one (square of) a chocolate bar. In Canada, 10 milligrams of THC is sold in a 32-gram bar of chocolate, resulting in an intoxicating dose being sold at a concentration of barely 0.03 %.
In the case of food safety levels, the concept of a maximum safe daily dose is used. The European Food Safety Agency (EFSA) uses the acute reference dose of a substance when carrying out risk assessments of food products and contaminants; the acute reference dose is the maximum dose per kilogram of body weight per day that is deemed safe. The EFSA reference dose for THC of 1 microgram per kilogram was calculated using an uncertainty factor of 30. The European Industrial Hemp Association considers that, in comparison with the uncertainty factor of 3 for opium alkaloids in foods such as poppy seeds, this produces a limit for THC in food that is excessively cautious (EIHA, 2017). In Austria and Switzerland, the uncertainty factor has been reduced to 10. In New Zealand, the maximum safe daily THC intake is 7 micrograms per kilogram body weight with no apparent problems reported, and Canada’s industrial hemp regulations of 2019 exclude products from the Cannabis Act if they contain no more than 10 micrograms of THC per gram of product.
This is all just for education and the launch of cERI and university of Florida and the lead by black and brown leaders from FAMU and Bazelet India our teams in education platforms lead by Robyn Frick and Michael Clinton with Bazelet Learning teams with CE and CME credits guided by prolific work of Dr Jahan Marcu and Bazelet team at Cornell lab driven in New York by a team that is on point
prepared for products in lab with safety development In consumer goods and consumables not just in pharmaceutical for future medicine or over the counter dietary supplement style products,
All cannabis and hemp strains currently in the global marketplace all contain THC unless altered or modified. Almost exclusively global breeding efforts over the last several decades has been focused on only a single effort- Increased THC concentrations. This linear breeding focus and federal law restricting research of cannabis is the vast wealth of therapeutic opportunities from low and no THC cannabis plants.
Panakeia has brought to market 0.000% THC cannabis, the world’s first THC free plants. Future development by Bazelet in Altha and its global teams bring safe and effective opportunity with clear legal path to consumer goods and opportunity for state regulation of THC through medical marijuana highly regulated and taxed programs already in place. States can benefit post COVID at their discretion for economic opportunities and allowable THC limits and Rule of law.
Meanwhile consumer goods companies can access Panakeia and other 0.00% plants for products. Forthright fiber varieties and grain and seed plants forthcoming that could prove to be the plant tissue culture lab in Altha, Florida’s defining moment as the farm is already led by Gary Hennen and David Grand etched in Florida Agriculture History as the first farm to harvest the worlds first 0.00% THC cannabis sativa L/ hemp and the first state certified 0.00% genetics available to farmers in 2021.
Wasted money is unnecessary wasted money for cannabis hemp marijuana. The horses and cows will not get high if there is no psychoactive THC. Children will get high from delta 8 if present even if the plant it came from was a 0.3% or less hemp plant.
The solution to everything including policework, tax and regulation, and a solution for the DEA is to differentiate cannabis based on its THC content.
Panakeia is scientifically different than cannabis hemp and cannabis marijuana. Panakeia is 0.00% THC, cannabis Hemp is Low THC and Marijuana High THC.
Stop wasting money, this new research bill gives the clear path and a simple THC test for workplace insurance, with provisions for medical patients under state regulated programs, full regulation under current state THC medical program.
including revenue fro. Plastic cards , and medical doctors oversight, and seed to sale tracking already in place to regulate and focus on safety and effectiveness of thc.
Hemp does not need thc!
No farmer wants thc, no cbd company wants thc, no Nike or Levi’s wants thc in their clothes or jeans.
Recently approved by Congress Research dollars must be focused on viability and safety of cannabis industry and effectiveness of current marketplace products. 0.00% THC hemp development and products from seeds, to young plants, to creams, food additives, and homeopathic medicinal remedies research money should gain approval for immediate access to research funding Congress passed through FAMU and HBCU who have been the victims of the war on drugs and current corporate cannabis space lack of black and brown entrepreneurial and highly success opportunity can give access to redevelopment in underprivileged communities and right the wrong of marijuana attack and lack of support amongst all to access new legal access to cannabis markets.
Voters and taxpayers want this nonsense to stop about Cannabis sativa L, hemp, marijuana, cannabis light, hot hemp or whatever one wishes to call it, will continue to stall and waste money on lawyers while taxpayers are left confused about what is right and wrong, what is safe, what is effective and what is good or bad about cannabis sativa L.
As of today, we have the democrats given an open check book to give people like Carl free high thc products and join a UF consortium research project in Florida. It’s good to use this funding the way they will but It’s time to stand up and talk about low THC medicine , high THC recreational products , and industrial hemp in Florida